Home Blog Page 228

Blog

Pharma Marketing Blog

Latest

Pharma’s Jekyll & Hyde

Pharma Guy - January 6, 2006

This Blogger’s Mission Statement

Pharma Guy - January 6, 2006

Pfizer – the Rodney Dangerfield of the Drug Industry

Pharma Guy - January 5, 2006

New Year’s Resolutions for Pharma

Pharma Guy - January 2, 2006

The BEST of Pharma Marketing Blog in 2005

Pharma Guy - December 29, 2005

Lilly’s Off-Label Promo Shenanigans

Pharma Guy - December 27, 2005

Pharmaceutical “Tribal Marketing”

Pharma Guy - December 15, 2005

Marketing “Acceptable Risk”

Pharma Guy - December 13, 2005

Merck’s Hand in the Cookie Jar

Pharma Guy - December 9, 2005

Less DTC, Better Public Image?

Pharma Guy - December 7, 2005

1...227228229...241 Page 228 of 241

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

From Messaging to Meaning: Why Pharma Marketing Needs a Stronger Point...

April 17, 2026

Stopwatch with pharmaceutical products and analytics dashboard representing speed in pharma marketing

The Velocity Problem: When Pharma Marketing Moves Slower Than the Market

April 17, 2026

Pharmaceutical marketing concept showing hidden stakeholders like policymakers, media, and algorithms influencing healthcare decisions

Invisible Audiences: The Stakeholders Pharma Marketing Ignores at Its Own Risk

April 16, 2026